[1]
E. Spector, M. J. Franklin, A. M. Truskinovsky, and A. Z. Dudek, “Sorafenib induces partial response in metastatic medullary thyroid carcinoma”, AO, vol. 49, no. 1, pp. 105–107, Jan. 2010.